| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000014389 |
| Receipt No. | R000016710 |
| Scientific Title | Pathophysiological analysis of Parkinson disease and related disorders using DAT scan and MRI |
| Date of disclosure of the study information | 2014/07/01 |
| Last modified on | 2019/12/30 (Ver. 5) |
| Basic information | ||
| Public title | Pathophysiological analysis of Parkinson disease and related disorders using DAT scan and MRI | |
| Acronym | Morphological and functional imaging assessment of Parkinson disease | |
| Scientific Title | Pathophysiological analysis of Parkinson disease and related disorders using DAT scan and MRI | |
| Scientific Title:Acronym | Morphological and functional imaging assessment of Parkinson disease | |
| Region |
|
|
| Condition | ||
| Condition | Parkinson disease and related disorders | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this work is to solve the pathophysiology of a Parkinson disease and related disorders by using multimodal neuroimaging including DAT scan and magnetic resonance imaging. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | activity of striatal dopamine transporters in Parkinson disease |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy control
Patients with Parkinson disease and related disorders |
|||
| Key exclusion criteria | 1. Patients who are severe hepatic dysfunction
2. Patients who are severe renal dysfunction or dialysis ESRD 3. Patients who are past history of hypersensitivity to Alcohol 4. Patients who are taking medicine which affects the uptake of [123I]-Ioflupane 5. Patients who have voiding dysfunction 6. Pregnant or woman of child-bearing potential 7. The woman under breast-feeding 8. Patients who were implanted metallic or electrical devices 9. Patients who are judged as inappropriate for inclusion by physicians |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Juntendo University Graduated School of Medicine | ||||||
| Division name | Department of Radiology | ||||||
| Zip code | 113-8431 | ||||||
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3813-3111 | ||||||
| kkamagat@juntendo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Juntendo University Graduated School of Medicine | ||||||
| Division name | Department of Radiology | ||||||
| Zip code | 113-8431 | ||||||
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3813-3111 | ||||||
| Homepage URL | |||||||
| kkamagat@juntendo.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Radiology, Juntendo University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | industry to support private universities building up their foundations of strategic research |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Juntendo hospital ethics committee |
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo |
| Tel | 03-3813-3111 |
| kenkyu5858@juntendo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Prospective study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016710 |